NEW YORK (TheStreet) -- RATINGS CHANGES
Johnson & Johnson (JNJ - Get Report) upgraded at Deutsche: JNJ was upgraded from Hold to Buy, Deutsche Bank said. $110 price target. Management meeting confirms that the company can sustain growth in the near term.
Stock Comments / EPS Changes
Archer Daniels (ADM - Get Report) estimates were reduced through 2016, Credit Suisse said. Company is seeing weaker conditions in its ethanol and agribusiness lines. Neutral rating and new $47 price target.
Allergan (AGN - Get Report) estimates, target cut at Leerink: Shares of AGN now seen reaching $311, according to Leerink Partners. Estimates also reduced, given the company's new guidance. Outperform rating.